Medios AG (OTCMKTS:MEDOF) Short Interest Update

Medios AG (OTCMKTS:MEDOF) was the target of a significant growth in short interest during the month of June. As of June 15th, there was short interest totaling 1,280 shares, a growth of 84.4% from the May 31st total of 694 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Medios Price Performance

MEDOF opened at C$13.64 on Thursday. Medios has a twelve month low of C$13.64 and a twelve month high of C$13.64. The business’s 50 day moving average is C$13.64 and its 200-day moving average is C$13.64.

Medios Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.